Charles Benson
- Endocrinology, Diabetes and Metabolism top 0.5%
- Molecular Biology top 5%
- Physiology top 5%
- Surgery top 5%
- Pharmacology top 1%
- Co-authors
- Axel HauptShweta UrvaXuewei CuiDeborah A. RobinsRuth E. GimenoZvonko MiličevićMichael A. NauckTamer Coşkun
- Topics
- Diabetes Treatment and Management (22 papers)Pharmacology and Obesity Treatment (12 papers)Pancreatic function and diabetes (8 papers)
- Journals
- The LancetCell MetabolismDiabetes
- Partner nations
- United StatesGermanySweden
In The Last Decade
Charles Benson
51 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 1.7k
- Molecular Biology 1.4k
- Physiology 736
- Surgery 695
- Pharmacology 691
Countries citing papers authored by Charles Benson
This map shows the geographic impact of Charles Benson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Benson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Benson more than expected).
Fields of papers citing papers by Charles Benson
This network shows the impact of papers produced by Charles Benson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Benson. The network helps show where Charles Benson may publish in the future.
Co-authorship network of co-authors of Charles Benson
This figure shows the co-authorship network connecting the top 25 collaborators of Charles Benson. A scholar is included among the top collaborators of Charles Benson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Benson. Charles Benson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 12 | |
| 4 | 23 | |
| 5 | 34 | |
| 6 | 21 | |
| 7 | 171 | |
| 8 | 92 | |
| 9 | 0 | |
| 10 | LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptbreakdown → | 603 |
| 11 | Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trialbreakdown → | 610 |
| 12 | 279 | |
| 13 | 12 | |
| 14 | 0 | |
| 15 | 9 | |
| 16 | 16 | |
| 17 | 58 | |
| 18 | 1 | |
| 19 | 54 | |
| 20 | 35 |
About Charles Benson
Charles Benson is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Gastroenterology, having authored 55 papers that have together received 3.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (22 papers), Pharmacology and Obesity Treatment (12 papers) and Pancreatic function and diabetes (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Pharmacology (691 citations) and Physiology (736 citations). Charles Benson has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Axel Haupt, Shweta Urva, Xuewei Cui, Deborah A. Robins, Ruth E. Gimeno, Zvonko Miličević, Michael A. Nauck, Tamer Coşkun, Joanna Van and Juan P. Frías. Their work appears in journals such as The Lancet, Cell Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.